NeuroMetrix NURO announced that it has entered an agreement with Handok Pharmaceuticals,
Inc. Under terms of the agreement, Handok will be the exclusive
distributor for NC-stat®
DPNCheck™ in the Republic of Korea. NC-stat DPNCheck is a
rapid, accurate and quantitative point-of-care test for diabetic
neuropathy. The product is used to detect neuropathy at an early stage
and to guide treatment. Diabetic peripheral neuropathy (DPN) is the most
common complication of diabetes, affecting over half of people with
diabetes. DPN causes significant morbidity including pain, increased
risk of falling in the elderly, and is the primary trigger for diabetic
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in